FDA records linked by MedtechLedger identify Djo, LLC as the applicant on premarket notification K262721 for the Spinalogic Bone Growth Stimulator. The submission was received July 31, 2026, and cleared September 29, 2026, with decision code SESE, described as Substantially Equivalent, under a Traditional clearance type. The device falls in the Orthopedic advisory committee and carries product code LOF, regulation number 890.5870, and Class II designation. The applicant address on the filing is in Carlsbad, California, and the clearance letter is addressed to counsel at Hogan Lovells in Washington, District of Columbia. [1][2]
Documented device and technology
The FDA record names the product as the Spinalogic Bone Growth Stimulator and classifies it as a non-invasive bone growth stimulator, device class 2, under regulation 890.5870. The openFDA fields list the device name as Stimulator, Bone Growth, Non-Invasive and the medical specialty as Orthopedic. The clearance letter repeats the trade name, regulation number and name, regulatory class and product code. [1][2]
The manufacturer's published product page describes CMF Spinalogic as a portable, battery-powered, micro-controlled, noninvasive bone growth stimulator indicated for skeletally mature patients as an adjunct electromagnetic treatment to primary lumbar spinal fusion surgery for one or two levels and primary anterior cervical fusion. That indication language comes from the manufacturer's page, not from the FDA clearance letter. [4]
The FDA review document notes that the device uses firmware to generate magnetic field treatment, maintain a treatment record and run a daily treatment time countdown. It also states the device is non-sterile and requires no sterilization, and references 9V battery installation with IP22 compliance. [2]
Filing scope and review details
K262721 was submitted as a Traditional 510(k) with no third-party review, and the record shows a Summary rather than a statement. The expedited review flag field is blank. The advisory committee and review advisory committee are both listed as Orthopedic, coded OR. [1]
The review document's comparison fields mark software and sterilization as unchanged from the predicate, while the software entry confirms firmware functions for magnetic field generation, treatment record keeping and countdown timing. The record does not describe clinical outcome data, and no performance results are stated in the cited material. [2]
Portfolio context and limits
The linked collection for this snapshot contains one 510(k) record, K262721, with a single SESE decision. That count reflects the retrieved filings as of the snapshot date and is not a measure of total company sales, total portfolio or safety performance. [1]
Separate PMA database pages appear among the numbered sources, but the cited excerpts contain only navigation and language-assistance text without device names, supplement details or applicant information. Those pages cannot be tied to Djo, LLC or to the Spinalogic device on the available text, so no PMA linkage is asserted here. [6][7][8][9]
Identity and attribution
Djo, LLC is the applicant of record on K262721. The manufacturer's product page publishes the Spinalogic brand and its stated indications, and that page is the source for those claims. No parent company, brand ownership, headquarters or commercial availability is confirmed by the FDA records cited, and the Carlsbad address is a filing address rather than a verified headquarters. [1][4]





